Sage Therapeutics: Looking For Positives Ahead Of Q1 Results [Seeking Alpha]
Sage Therapeutics, Inc. (SAGE)
Last sage therapeutics, inc. earnings: 2/27 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.sagerx.com/investor-relations
Company Research
Source: Seeking Alpha
SummaryEarlier this month Sage announced it will cut 340 jobs - or 53% of its workforce - mainly from its Zulresso division to extend its cash runway.The failure of SAGE-217 in its pivotal phase 3 MOUNTAIN trial in December 2019 (for MDD) triggered a market sell-off that saw SAGE stock price tumble 61% to $58.Sage's only approved candidate Zulresso - approved for treatment of postpartum depression - launched commercially in June '19 and made sales of ~$4m that year.The company's operating expenses in 2019 were $714m - Sage has $1.03bn of current assets to fund operations going forward.CNS treatments are notoriously hard to develop and the cost of failure is high, as Sage is discovering. I can't see where gains are coming from this year, but there's a sense SAGE-217 could come back and there are other promising candidates.Investment ThesisIn this article I will discuss the progress of Sage Therapeutics (The company trades at a significant discount to its September '19 high of $190, at
Show less
Read more
Impact Snapshot
Event Time:
SAGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SAGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SAGE alerts
High impacting Sage Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics